Plasma vascular endothelial growth factor level is elevated in patients with multivessel coronary artery disease

被引:25
作者
Nakajima, K
Tabata, S
Yamashita, Y
Kusuhara, M
Arakawa, K
Ohmori, R
Yonemura, A
Higashi, K
Ayaori, M
Nakamura, J
Ohsuzu, F
机构
[1] Natl Def Med Coll, Dept Internal Med 1, Saitama, Japan
[2] Mitsukoshi Hlth & Welfare Fdn, Tokyo, Japan
关键词
vascular endothelial growth factor; ischemia; atherosclerosis; severity; coronary artery disease; cytokine;
D O I
10.1002/clc.4960270509
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Vascular endothelial growth factor (VEGF) has been implicated in both angiogenesis and ischemia. However, the relationship between plasma VEGF level and coronary artery disease remains unknown. Hypothesis: Plasma VEGF level may be associated with severe coronary artery disease and other cardiovascular risk factors. Methods: We examined plasma VEGF concentration and coronary risk factors in 73 patients who underwent coronary angiography and 70 apparently healthy control subjects. According to the number of the three major coronary vessels with significant (greater than or equal to 75%) stenosis, we divided the patients into two groups: the mild stenosis group (0- and single-vessel disease. n = 36) and the severe stenosis group (double- and triple-vessel disease, n = 37). Results: The loa VEGF value of the severe stenosis group was significantly higher than that of the mild sterrosis (p < 0.05) and control groups (p < 0.05). Furthermore, there was a significant positive trend in the log VEGF value according to the number of vessels with significant stenosis (p = 0.016). However. there was no significant difference in log VEGF value between the mild stenosis and control groups. Soluble vascular cellular adhesion molecule, soluble intracellular adhesion molecule, and other coronary risk factors were found to be associated with the presence of vessel stenosis. Conclusion: Unlike established coronary risk factors, the plasma VEGF level may be associated with only severe coronary ischemia such as multiple coronary vessel disease.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 34 条
[1]   Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flow [J].
Agrawal, R ;
Conway, GS ;
Sladkevicius, P ;
Payne, NN ;
Bekir, J ;
Campbell, S ;
Tan, SL ;
Jacobs, HS .
CLINICAL ENDOCRINOLOGY, 1999, 50 (01) :101-106
[2]  
Arakawa K, 1998, J Cardiol, V32, P379
[3]  
BANAI S, 1994, CARDIOVASC RES, V28, P1173
[4]   INDIRECT ANGIOGENIC CYTOKINES UP-REGULATE VEGF AND BFGF GENE-EXPRESSION IN VASCULAR SMOOTH-MUSCLE CELLS, WHEREAS HYPOXIA UP-REGULATES VEGF EXPRESSION ONLY [J].
BROGI, E ;
WU, TG ;
NAMIKI, A ;
ISNER, JM .
CIRCULATION, 1994, 90 (02) :649-652
[5]   TUMOR VASCULAR-PERMEABILITY FACTOR STIMULATES ENDOTHELIAL-CELL GROWTH AND ANGIOGENESIS [J].
CONNOLLY, DT ;
HEUVELMAN, DM ;
NELSON, R ;
OLANDER, JV ;
EPPLEY, BL ;
DELFINO, JJ ;
SIEGEL, NR ;
LEIMGRUBER, RM ;
FEDER, J .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1470-1478
[6]   THE EXPRESSION OF THE ADHESION MOLECULES ICAM-1, VCAM-1, PECAM, AND E-SELECTIN IN HUMAN ATHEROSCLEROSIS [J].
DAVIES, MJ ;
GORDON, JL ;
GEARING, AJH ;
PIGOTT, R ;
WOOLF, N ;
KATZ, D ;
KYRIAKOPOULOS, A .
JOURNAL OF PATHOLOGY, 1993, 171 (03) :223-229
[7]   Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer [J].
Duque, JLF ;
Loughlin, KR ;
Adam, RM ;
Kantoff, PW ;
Zurakowski, D ;
Freeman, MR .
UROLOGY, 1999, 54 (03) :523-527
[8]   VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR - AN IMPORTANT MEDIATOR OF ANGIOGENESIS IN MALIGNANCY AND INFLAMMATION [J].
DVORAK, HF ;
DETMAR, M ;
CLAFFEY, KP ;
NAGY, JA ;
VANDEWATER, L ;
SENGER, DR .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) :233-235
[9]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[10]  
Fuhrmann-Benzakein E, 2000, INT J CANCER, V85, P40